Show Summary Details
Page of

Allergic Rhinitis: Comorbid 

Allergic Rhinitis: Comorbid
Chapter:
Allergic Rhinitis: Comorbid
Author(s):

Robert M. Naclerio

and Ruby Pawankar

DOI:
10.1093/med/9780199918065.003.0018
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 April 2021

Allergic rhinitis is the most common atopic disease, with an increasing prevalence worldwide. It is an immunoglobulin E–mediated inflammatory disease of the nasal mucosa, characterized by symptoms of nasal itching, sneezing, runny nose, and stuffy nose. The stuffy nose is the most burdensome symptom to patients, but the itch and sneeze are the most characteristic. Although it is not a fatal disease, allergic rhinitis has a negative impact on the patient’s quality of life (QOL), which is detected not only on disease-specific QOL measures but also on general QOL measures such as the SF36. Sleep, presenteeism, mood and cognition, and participation in sports and leisure activities are all affected, causing a great physical and financial burden on the patient.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.